OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on GGPeps (GYC) tirzepatide .

To answer Dr.EM_Chicago: I get my labs done through Quest every 3 months.

Quick update: my latest labs came back even better. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

Relevant to GGPeps (GYC) tirzepatide — here is my latest bloodwork comparison:

Key improvements: A1C 7.2% → 5.3%, triglycerides 239 → 109 mg/dL, hsCRP 6.0 → 0.9 mg/L. All on tirzepatide for 7 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

Subscribing to this thread. GGPeps (GYC) tirzepatide is exactly what I've been researching. 🙏

Slightly tangential to GGPeps (GYC) tirzepatide but FranDenver reminded me — has the insurance landscape changed recently?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

KetoKyle said:

Thank you all for the thoughtful replies on GGPeps (GYC) tirzepatide

This is exactly right. KetoKyle articulated what I have been trying to explain to my friends for months. The GGPeps (GYC) tirzepatide aspect is what made the difference for me.